Linkgenesis Co., Ltd. (KOSDAQ:219420)

Revance Therapeutics Statistics

Total Valuation

Linkgenesis has a market cap or net worth of KRW 56.61 billion. The enterprise value is 23.09 billion.

Market Cap	56.61B
Enterprise Value	23.09B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Linkgenesis has 11.25 million shares outstanding.

Current Share Class	11.25M
Shares Outstanding	11.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.28%
Owned by Institutions (%)	4.23%
Float	6.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.68
PB Ratio	1.26
P/TBV Ratio	1.33
P/FCF Ratio	50.39
P/OCF Ratio	41.40
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.48, with an EV/FCF ratio of 20.55.

EV / Earnings	-74.47
EV / Sales	1.91
EV / EBITDA	22.48
EV / EBIT	87.69
EV / FCF	20.55

Financial Position

The company has a current ratio of 12.29, with a Debt / Equity ratio of 0.00.

Current Ratio	12.29
Quick Ratio	11.60
Debt / Equity	0.00
Debt / EBITDA	0.24
Debt / FCF	0.18
Interest Coverage	5.37

Financial Efficiency

Return on equity (ROE) is -1.30% and return on invested capital (ROIC) is 0.13%.

Return on Equity (ROE)	-1.30%
Return on Assets (ROA)	0.12%
Return on Invested Capital (ROIC)	0.13%
Return on Capital Employed (ROCE)	0.21%
Revenue Per Employee	104.33M
Profits Per Employee	-2.67M
Employee Count	116
Asset Turnover	0.25
Inventory Turnover	31.20

Taxes

In the past 12 months, Linkgenesis has paid 210.82 million in taxes.

Income Tax	210.82M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.34% in the last 52 weeks. The beta is 0.63, so Linkgenesis's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+3.34%
50-Day Moving Average	5,174.00
200-Day Moving Average	5,465.18
Relative Strength Index (RSI)	45.76
Average Volume (20 Days)	32,645

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Linkgenesis had revenue of KRW 12.10 billion and -310.05 million in losses. Loss per share was -28.00.

Revenue	12.10B
Gross Profit	3.67B
Operating Income	96.53M
Pretax Income	-373.70M
Net Income	-310.05M
EBITDA	860.30M
EBIT	96.53M
Loss Per Share	-28.00

Balance Sheet

The company has 35.52 billion in cash and 206.21 million in debt, giving a net cash position of 35.32 billion or 3,137.96 per share.

Cash & Cash Equivalents	35.52B
Total Debt	206.21M
Net Cash	35.32B
Net Cash Per Share	3,137.96
Equity (Book Value)	45.10B
Book Value Per Share	3,847.36
Working Capital	36.39B

Cash Flow

In the last 12 months, operating cash flow was 1.37 billion and capital expenditures -243.74 million, giving a free cash flow of 1.12 billion.

Operating Cash Flow	1.37B
Capital Expenditures	-243.74M
Free Cash Flow	1.12B
FCF Per Share	99.83

Margins

Gross margin is 30.32%, with operating and profit margins of 0.80% and -2.56%.

Gross Margin	30.32%
Operating Margin	0.80%
Pretax Margin	-3.09%
Profit Margin	-2.56%
EBITDA Margin	7.11%
EBIT Margin	0.80%
FCF Margin	9.28%

Dividends & Yields

Linkgenesis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.55%
FCF Yield	1.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 23, 2018. It was a forward split with a ratio of 5.0924275602.

Last Split Date	Feb 23, 2018
Split Type	Forward
Split Ratio	5.0924275602

Scores

Linkgenesis has an Altman Z-Score of 12.51 and a Piotroski F-Score of 3.

Altman Z-Score	12.51
Piotroski F-Score	3